home / stock / afmd / afmd short
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,789,689 |
Total Actual Volume | 25,976,466 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 8 |
No Change Days | 9 |
Averages | |
---|---|
Average Short Volume | 139,484 |
Average Short Percentage | 47.75% |
Is there a AFMD Short Squeeze or Breakout about to happen?
See the AFMD Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2022-06-30 | 2.75 | 2.77 | 2.795 | 2.695 | 653,948 | 53,547 | 45.6306 |
2022-06-29 | 2.78 | 2.81 | 2.82 | 2.695 | 600,760 | 55,272 | 61.3472 |
2022-06-28 | 2.96 | 2.78 | 2.96 | 2.75 | 1,208,236 | 222,113 | 74.8495 |
2022-06-27 | 2.71 | 2.92 | 2.975 | 2.71 | 1,251,199 | 150,936 | 55.1544 |
2022-06-24 | 2.77 | 2.71 | 2.865 | 2.71 | 5,447,126 | 167,917 | 55.9796 |
2022-06-23 | 2.76 | 2.84 | 2.85 | 2.7 | 1,099,118 | 190,444 | 69.7873 |
2022-06-22 | 2.5 | 2.73 | 2.8 | 2.46 | 1,094,600 | 133,075 | 41.6642 |
2022-06-21 | 2.55 | 2.56 | 2.655 | 2.54 | 1,023,806 | 99,228 | 37.4919 |
2022-06-16 | 2.32 | 2.32 | 2.35 | 2.23 | 728,336 | 68,001 | 35.8958 |
2022-06-15 | 2.32 | 2.37 | 2.4499 | 2.26 | 1,476,096 | 221,333 | 58.2725 |
2022-06-14 | 2.37 | 2.27 | 2.4093 | 2.25 | 790,620 | 135,670 | 48.4924 |
2022-06-13 | 2.47 | 2.37 | 2.5 | 2.34 | 981,346 | 138,477 | 48.9671 |
2022-06-09 | 2.89 | 2.74 | 3 | 2.73 | 649,794 | 92,792 | 42.1337 |
2022-06-08 | 2.94 | 2.92 | 3.065 | 2.88 | 1,140,450 | 203,576 | 56.4888 |
2022-06-06 | 3.13 | 2.82 | 3.18 | 2.79 | 1,501,783 | 182,151 | 38.6885 |
2022-06-03 | 3.11 | 3.1 | 3.24 | 3.035 | 1,157,873 | 96,472 | 33.1140 |
2022-06-02 | 3.12 | 3.1 | 3.1883 | 3.07 | 1,427,092 | 121,734 | 20.4131 |
2022-06-01 | 3.11 | 3.13 | 3.21 | 2.92 | 1,571,232 | 209,930 | 45.7520 |
2022-05-31 | 3.31 | 3.1 | 3.31 | 3.04 | 948,784 | 176,712 | 70.0713 |
2022-05-27 | 3.15 | 3.2 | 3.245 | 3.058 | 1,224,267 | 70,309 | 14.8939 |
Affimed N.V. Company Name:
AFMD Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
Independent advisory panel to be made up of distinguished, key opinion leaders with scientific and clinical expertise in innate immunity and oncology Scientific Advisory Board to provide guidance on the Company’s development strategy across assets and assessment of emerg...
AFM28 induced potent, effective, and specific anti-tumor activity against CD123-positive cells irrespective of mutational status Study demonstrated specific anti-tumor response even at low levels of CD123 expression with no evidence for off-target cytotoxic activity towards CD123-nega...
AFM13 monotherapy: Completed enrollment in the REDIRECT study for patients with relapsed or refractory PTCL; on track to report topline data in the fourth quarter of 2022 AFM13 combination with NK cells: Reported data at AACR 2022 showing a 100% objective response rate (ORR) and ...